DT Investment Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.98M | Buy |
30,995
+334
| +1% | +$39.1K | 0.3% | 50 |
|
|
2026
Q1 | $3.69M | Sell |
30,661
-3,984
| -11% | -$460K | 0.31% | 50 |
|
|
2025
Q4 | $3.65M | Hold |
34,645
| – | – | 0.3% | 50 |
|
|
2025
Q3 | $2.91M | Hold |
34,645
| – | – | 0.25% | 54 |
|
|
2025
Q2 | $2.74M | Hold |
34,645
| – | – | 0.25% | 51 |
|
|
2025
Q1 | $3.11M | Hold |
34,645
| – | – | 0.3% | 50 |
|
|
2024
Q4 | $3.45M | Sell |
34,645
-5,206
| -13% | -$537K | 0.29% | 51 |
|
|
2024
Q3 | $4.53M | Sell |
39,851
-19
| -0% | -$2.26K | 0.37% | 45 |
|
|
2024
Q2 | $4.94M | Buy |
39,870
+295
| +0.7% | +$38K | 0.44% | 38 |
|
|
2024
Q1 | $5.22M | Sell |
39,575
-8,471
| -18% | -$1.04M | 0.53% | 30 |
|
|
2023
Q4 | $5.85M | Buy |
48,046
+158
| +0.3% | +$16.4K | 0.63% | 30 |
|
|
2023
Q3 | $4.93M | Buy |
47,888
+11,028
| +30% | +$1.19M | 0.6% | 31 |
|
|
2023
Q2 | $3.88M | Hold |
36,860
| – | – | 0.44% | 37 |
|
|
2023
Q1 | $4.29M | Hold |
36,860
| – | – | 0.52% | 35 |
|
|
2022
Q4 | $4.09M | Hold |
36,860
| – | – | 0.54% | 36 |
|
|
2022
Q3 | $3.17M | Sell |
36,860
-3,299
| -8% | -$295K | 0.52% | 33 |
|
|
2022
Q2 | $3.66M | Buy |
40,159
+2,284
| +6% | +$202K | 0.54% | 33 |
|
|
2022
Q1 | $3.11M | Buy |
37,875
+2,867
| +8% | +$226K | 0.4% | 38 |
|
|
2021
Q4 | $2.68M | Sell |
35,008
-1,973
| -5% | -$157K | 0.35% | 41 |
|
|
2021
Q3 | $2.78M | Buy |
36,981
+6,081
| +20% | +$462K | 0.37% | 43 |
|
|
2021
Q2 | $2.4M | Sell |
30,900
-18,220
| -37% | -$1.36M | 0.33% | 45 |
|
|
2021
Q1 | $3.61M | Hold |
49,120
| – | – | 0.52% | 34 |
|
|
2020
Q4 | $3.83M | Hold |
49,120
| – | – | 0.61% | 29 |
|
|
2020
Q3 | $3.89M | Hold |
49,120
| – | – | 0.56% | 28 |
|
|
2020
Q2 | $3.62M | Sell |
49,120
-84
| -0.2% | -$6.32K | 0.45% | 29 |
|
|
2020
Q1 | $3.61M | Sell |
49,204
-4,166
| -8% | -$327K | 0.59% | 23 |
|
|
2019
Q4 | $4.63M | Buy |
+53,370
| New | +$4.38M | 0.42% | 53 |
|
|
2018
Q2 | – | Sell |
-4,586
| Closed | -$238K | – | 84 |
|
|
2018
Q1 | $238K | Buy |
+4,586
| New | +$248K | 0.04% | 77 |
|
|
2017
Q4 | – | Sell |
-3,884
| Closed | -$237K | – | 95 |
|
|
2017
Q3 | $237K | Buy |
+3,884
| New | +$235K | 0.04% | 83 |
|
|
2015
Q3 | – | Sell |
-4,168
| Closed | -$226K | – | 97 |
|
|
2015
Q2 | $226K | Sell |
4,168
-7,127
| -63% | -$400K | 0.06% | 117 |
|
|
2015
Q1 | $620K | Buy |
11,295
+578
| +5% | +$32.7K | 0.19% | 43 |
|
|
2014
Q4 | $581K | Sell |
10,717
-1,001
| -9% | -$55.8K | 0.18% | 45 |
|
|
2014
Q3 | $663K | Buy |
11,718
+2,750
| +31% | +$154K | 0.22% | 43 |
|
|
2014
Q2 | $495K | Buy |
8,968
+1,006
| +13% | +$54.9K | 0.17% | 49 |
|
|
2014
Q1 | $431K | Sell |
7,962
-1,658
| -17% | -$85.9K | 0.17% | 43 |
|
|
2013
Q4 | $459K | Buy |
9,620
+1,527
| +19% | +$69.8K | 0.19% | 44 |
|
|
2013
Q3 | $367K | Buy |
8,093
+324
| +4% | +$14.8K | 0.15% | 47 |
|
|
2013
Q2 | $344K | Buy |
+7,769
| New | +$347K | 0.16% | 44 |
|
Other funds holding MRK
ECSS
DT Investment Partners's MRK Position: Q2 2026 in Review
DT Investment Partners increased its Merck (MRK) stake by 1.1% in Q2 2026, buying an estimated $39.1K and bringing the position to 30,995 shares worth $3.98M. The position accounts for 0.3% of the portfolio, ranked #50.
DT Investment Partners first reported a position in MRK in Q2 2013 and has held it in 38 quarters since. The position peaked at $5.85M in Q4 2023. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- DT Investment Partners held 30,995 shares of Merck worth $3.98M as of Q2 2026.
- DT Investment Partners bought 334 Merck shares in Q2 2026, an estimated $39.1K.
- Merck made up 0.3% of DT Investment Partners's portfolio in Q2 2026, its #50 holding.
- DT Investment Partners first reported a position in Merck in Q2 2013 and has held it in 38 quarters since.
- DT Investment Partners's Merck position peaked at $5.85M in Q4 2023.
- 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.